Top

Published in:

2019 | OriginalPaper | Chapter

3. Poly-lactide/Poly-lactide-co-glycolide-Based Delivery System for Bioactive Compounds Against Microbes

Authors : Robin Kumar, Divya Jha, Amulya K. Panda

Published in: Pharmaceuticals from Microbes

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

Infectious diseases caused by pathogenic microorganisms are one of the leading causes of mortality worldwide. For many of these diseases, prophylactic and therapeutic treatments are available in the form of vaccines and drugs. Novel discoveries in the pathophysiology and immunology of these diseases have led to the identification of contributing factors to the progress of these diseases. Our immune system puts forth a strong defense against these infections, but the microbes develop strategies to evade the immune system and survive inside the host. There is an ongoing hunt to look for potent therapeutic agents against these harmful bugs. These therapeutic drugs also need to be delivered effectively for long-lasting protection. This has led to the enhanced emphasis on the type of a suitable delivery system that can carry these agents inside the human body in its bioactive form. Hence, to achieve newer ways to deal with infection, we need better delivery systems as powerful tools for infection control and treatment.

Biodegradable and biocompatible polymeric particles such as poly(lactic acid) and poly(lactic-co-glycolic acid) have emerged as one of the efficient delivery systems for many life-saving drugs. These polymers offer several advantages such as targeted delivery, sustained release, and maintenance of bioactivity; it also leads to dose sparing by reducing the exposure of bioactive molecules in the circulation. The polymeric particles are being extensively studied in several applications as delivery systems due to their ability to exhibit a broad range of desirable properties. The present review focuses on the polymer-based particulate delivery system as a plausible solution to circumvent the shortcomings of conventional therapeutic and prophylactic systems, and it discusses some of the methods for their preparation as well as mechanisms of action against infection. Here we also review the cellular interaction of nanoparticles because this interaction influences the effectiveness of the particles. The present review aims at different preparation methods of poly-lactide/poly-lactide-co-glycolide-based particles, their properties as carriers of bioactive molecules, and applications of polymeric particle-based bioactive delivery systems against microbes with an emphasis on recent findings. This review sheds light on the latest applications of particle-based delivery systems attempting to provide an updated study about the field.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

previous chapter Live-Attenuated Bacterial Vectors for Delivery of Mucosal Vaccines, DNA Vaccines, and Cancer Immunotherapy

next chapter Drug Delivery Systems Based on Pullulan Polysaccharides and Their Derivatives

Admane P, Gupta J, Ancy I, Kumar R, Panda AK (2017) Design and evaluation of antibiotic releasing self-assembled scaffolds at room temperature using biodegradable polymer particles. Int J Pharm 520(1):284–296. https://doi.org/10.1016/j.ijpharm.2017.01.071 CrossRef

Agallou M, Margaroni M, Athanasiou E, Toubanaki DK, Kontonikola K, Karidi K, Kammona O, Kiparissides C, Karagouni E (2017) Identification of BALB/c immune markers correlated with a partial protection to Leishmania infantum after vaccination with a rationally designed multi-epitope cysteine protease a peptide-based nanovaccine. PLoS Negl Trop Dis 11(1):e0005311. https://doi.org/10.1371/journal.pntd.0005311 CrossRef

Aldrian G, Vaissière A, Konate K, Seisel Q, Vivès E, Fernandez F, Viguier V, Genevois C, Couillaud F, Démèné H (2017) PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo. J Control Release 256:79–91. https://doi.org/10.1016/j.jconrel.2017.04.012 CrossRef

Allahyari M, Mohit E (2016) Peptide/protein vaccine delivery system based on PLGA particles. Hum Vaccin Immunother 12(3):806–828. https://doi.org/10.1080/21645515.2015.1102804 CrossRef

Allahyari M, Mohabati R, Amiri S, Rastaghi ARE, Babaie J, Mahdavi M, Vatanara A, Golkar M (2016) Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii. Exp Parasitol 170:236–246. https://doi.org/10.1016/j.exppara.2016.09.008 CrossRef

Anderson JM, Shive MS (2012) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 64:72–82. https://doi.org/10.1016/S0169-409X(97)00048-3 CrossRef

Athanasiou E, Agallou M, Tastsoglou S, Kammona O, Hatzigeorgiou A, Kiparissides C, Karagouni E (2017) A poly (lactic-co-glycolic) acid nanovaccine based on chimeric peptides from different Leishmania infantum proteins induces dendritic cells maturation and promotes peptide-specific IFNγ-producing CD8+ T cells essential for the protection against experimental visceral Leishmaniasis. Front Immunol 8:684. https://doi.org/10.3389/fimmu.2017.00684 CrossRef

Basu A, Kunduru KR, Doppalapudi S, Domb AJ, Khan W (2016) Poly (lactic acid) based hydrogels. Adv Drug Deliv Rev 107:192–205. https://doi.org/10.1016/j.addr.2016.07.004 CrossRef

Bhatt PC, Verma A, Al-Abbasi FA, Anwar F, Kumar V, Panda BP (2017) Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease. Int J Nanomedicine 12:8749–8768. https://doi.org/10.2147/IJN.S144545

Brady JM, Cutright DE, Miller RA, Battistone GC, Hunsuck EE (1973) Resorption rate, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res A 7(2):155–166. https://doi.org/10.1002/jbm.820070204 CrossRef

Bruno C, Agnolon V, Berti F, Bufali S, O’Hagan DT, Baudner BC (2016) The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine. Eur J Pharm Biopharm 105:1–8. https://doi.org/10.1016/j.ejpb.2016.05.013 CrossRef

Cai H, Liang Z, Huang W, Wen L, Chen G (2017) Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery. Int J Pharm 532(1):55–65. https://doi.org/10.1016/j.ijpharm.2017.08.084 CrossRef

Carreño JM, Perez-Shibayama C, Gil-Cruz C, Printz A, Pastelin R, Isibasi A, Chariatte D, Tanoue Y, Lopez-Macias C, Gander B (2016) PLGA-microencapsulation protects Salmonella typhi outer membrane proteins from acidic degradation and increases their mucosal immunogenicity. Vaccine 34(35):4263–4269. https://doi.org/10.1016/j.vaccine.2016.05.036 CrossRef

Chong CS, Cao M, Wong WW, Fischer KP, Addison WR, Kwon GS, Tyrrell DL, Samuel J (2005) Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release 102(1):85–99. https://doi.org/10.1016/j.jconrel.2004.09.014 CrossRef

Coelho JF, Ferreira PC, Alves P, Cordeiro R, Fonseca AC, Góis JR, Gil MH (2010) Drug delivery systems: advanced technologies potentially applicable in personalized treatments. EPMA J 1(1):164–209. https://doi.org/10.1007/s13167-010-0001-x CrossRef

Cruz J, Flórez J, Torres R, Urquiza M, Gutiérrez J, Guzmán F, Ortiz C (2017) Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly (lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157: H7 and methicillin resistant Staphylococcus aureus (MRSA). Nanotechnology 28(13):135102. https://doi.org/10.1088/1361-6528/aa5f63 CrossRef

Dalzon B, Lebas C, Jimenez G, Gutjahr A, Terrat C, Exposito J-Y, Verrier B, Lethias C (2016) Poly (lactic acid) nanoparticles targeting α5β1 integrin as vaccine delivery vehicle, a prospective study. PLoS One 11(12):e0167663. https://doi.org/10.1371/journal.pone.0167663 CrossRef

Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161(2):505–522. https://doi.org/10.1016/j.jconrel.2012.01.043 CrossRef

Dhakal S, Hiremath J, Bondra K, Lakshmanappa YS, Shyu D-L, Ouyang K, Kang K-i, Binjawadagi B, Goodman J, Tabynov K (2017) Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs. J Control Release 247:194–205. https://doi.org/10.1016/j.jconrel.2016.12.039 CrossRef

Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F (2011) Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine 6:877. https://doi.org/10.2147/IJN.S18905 CrossRef

Du X, Wang J-L, Iqbal S, Li H, Cao Z, Wang Y-C, Du J, Wang J (2018) The effect of surface charge on oral absorption of polymeric nanoparticles. Biomater Sci 6:642. https://doi.org/10.1039/C7BM01096F CrossRef

Ekanem EE, Zhang Z, Vladisavljevic GT (2017a) Facile production of biodegradable bipolymer patchy and patchy Janus particles with controlled morphology by microfluidic routes. Langmuir 33(34):8476–8482. https://doi.org/10.1021/acs.langmuir.7b02506 CrossRef

Ekanem EE, Zhang Z, Vladisavljević GT (2017b) Facile microfluidic production of composite polymer core-shell microcapsules and crescent-shaped microparticles. J Colloid Interface Sci 498:387–394. https://doi.org/10.1016/j.jcis.2017.03.067 CrossRef

El-Hammadi MM, Delgado ÁV, Melguizo C, Prados JC, Arias JL (2017) Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. Int J Pharm 516(1):61–70. https://doi.org/10.1016/j.ijpharm.2016.11.012 CrossRef

Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 7:5577. https://doi.org/10.2147/IJN.S36111 CrossRef

Gagliardi M, Bertero A, Bifone A (2017) Molecularly imprinted biodegradable nanoparticles. Sci Rep 7. https://doi.org/10.1038/srep40046

Genta I, Colonna C, Conti B, Caliceti P, Salmaso S, Speziale P, Pietrocola G, Chiesa E, Modena T, Dorati R (2016) CNA-loaded PLGA nanoparticles improve humoral response against S. aureus-mediated infections in a mouse model: subcutaneous vs. nasal administration strategy. J Microencapsul 33(8):750–762. https://doi.org/10.1080/02652048.2016.1260661 CrossRef

Gourdon B, Chemin C, Moreau A, Arnauld T, Baumy P, Cisternino S, Péan J-M, Declèves X (2017) Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir. Int J Pharm 529(1–2):357–370. https://doi.org/10.1016/j.ijpharm.2017.07.024 CrossRef

Gregory AE, Titball R, Williamson D (2013) Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 3:13. https://doi.org/10.3389/fcimb.2013.00013 CrossRef

Gutierro I, Hernandez R, Igartua M, Gascon A, Pedraz J (2002) Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 21(1):67–77. https://doi.org/10.1016/S0264-410X(02)00435-8 CrossRef

Gutjahr A, Phelip C, Coolen A-L, Monge C, Boisgard A-S, Paul S, Verrier B (2016) Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting. Vaccine 4(4):34. https://doi.org/10.3390/vaccines4040034 CrossRef

Hillaireau H, Couvreur P (2009) Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66(17):2873–2896. https://doi.org/10.1007/s00018-009-0053-z CrossRef

Hiremath J, Kang K-i, Xia M, Elaish M, Binjawadagi B, Ouyang K, Dhakal S, Arcos J, Torrelles JB, Jiang X (2016) Entrapment of H1N1 influenza virus derived conserved peptides in PLGA nanoparticles enhances T cell response and vaccine efficacy in pigs. PLoS One 11(4):e0151922. https://doi.org/10.1371/journal.pone.0151922 CrossRef

Huang N, Lu S, Liu X-G, Zhu J, Wang Y-J, Liu R-T (2017) PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer’s disease mice. Oncotarget 8(46):81001. https://doi.org/10.18632/oncotarget.20944 CrossRef

Hussain M, Xie J, Hou Z, Shezad K, Xu J, Wang K, Gao Y, Shen L, Zhu J (2017) Regulation of drug release by tuning surface textures of biodegradable polymer microparticles. ACS Appl Mater Interfaces 9(24):14391–14400. https://doi.org/10.1021/acsami.7b02002 CrossRef

James R, Manoukian OS, Kumbar SG (2016) Poly (lactic acid) for delivery of bioactive macromolecules. Adv Drug Deliv Rev 107:277–288. https://doi.org/10.1016/j.addr.2016.06.009 CrossRef

Jannuzzi GP, de Araújo Souza N, Françoso KS, Pereira RH, Santos RP, Kaihami GH, de Almeida JRF, Batista WL, Amaral AC, Maranhão AQ (2017) Therapeutic treatment with scFv–PLGA nanoparticles decreases pulmonary fungal load in a murine model of paracoccidioidomycosis. Microbes Infect 20:48. https://doi.org/10.1016/j.micinf.2017.09.003 CrossRef

Johansen P, Men Y, Merkle HP, Gander B (2000) Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. Eur J Pharm Biopharm 50(1):129–146. https://doi.org/10.1016/S0939-6411(00)00079-5 CrossRef

Kasturi SP, Kozlowski PA, Nakaya HI, Burger MC, Russo P, Pham M, Kovalenkov Y, Silveira EL, Havenar-Daughton C, Burton SL (2017) Adjuvanting a simian immunodeficiency virus vaccine with toll-like receptor ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5α restrictive macaques. J Virol 91(4):e01844–e01816. https://doi.org/10.1128/JVI.01844-16 CrossRef

Koutsiouki K, Angelopoulou A, Ioannou E, Voulgari E, Sergides A, Magoulas GE, Bakandritsos A, Avgoustakis K (2017) TAT peptide-conjugated magnetic PLA-PEG nanocapsules for the targeted delivery of paclitaxel: in vitro and cell studies. AAPS PharmSciTech 18(3):769–781. https://doi.org/10.1208/s12249-016-0560-9 CrossRef

Li P, Asokanathan C, Liu F, Khaing KK, Kmiec D, Wei X, Song B, Xing D, Kong D (2016) PLGA nano/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1/Th17 immune response in a murine model. Int J Pharm 513(1):183–190. https://doi.org/10.1016/j.ijpharm.2016.08.059 CrossRef

Liu L, Cao F, Liu X, Wang H, Zhang C, Sun H, Wang C, Leng X, Song C, Kong D (2016a) Hyaluronic acid-modified cationic lipid–PLGA hybrid nanoparticles as a nanovaccine induce robust humoral and cellular immune responses. ACS Appl Mater Interfaces 8(19):11969–11979. https://doi.org/10.1021/acsami.6b01135 CrossRef

Liu L, Ma P, Wang H, Zhang C, Sun H, Wang C, Song C, Leng X, Kong D, Ma G (2016b) Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles. J Control Release 225:230–239. https://doi.org/10.1016/j.jconrel.2016.01.050 CrossRef

Marasini N, Khalil ZG, Giddam AK, Ghaffar KA, Hussein WM, Capon RJ, Batzloff MR, Good MF, Skwarczynski M, Toth I (2016) Lipid core peptide/poly (lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against group A streptococcus. Int J Pharm 513(1):410–420. https://doi.org/10.1016/j.ijpharm.2016.09.057 CrossRef

Margaroni M, Agallou M, Kontonikola K, Karidi K, Kammona O, Kiparissides C, Gaitanaki C, Karagouni E (2016) PLGA nanoparticles modified with a TNFα mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation. Eur J Pharm Biopharm 105:18–31. https://doi.org/10.1016/j.ejpb.2016.05.018 CrossRef

Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, Wu Z, Sun K (2018) Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease. Int J Nanomedicine 13:705. https://doi.org/10.2147/IJN.S151474 CrossRef

Metz SW, Tian S, Hoekstra G, Yi X, Stone M, Horvath K, Miley MJ, DeSimone J, Luft CJ, de Silva AM (2016) Precisely molded nanoparticle displaying DENV-E proteins induces robust serotype-specific neutralizing antibody responses. PLoS Negl Trop Dis 10(10):e0005071. https://doi.org/10.1371/journal.pntd.0005071 CrossRef

Mitragotri S, Burke PA, Langer R (2014) Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov 13(9):655. https://doi.org/10.1038/nrd4363 CrossRef

Murariu M, Dubois P (2016) PLA composites: from production to properties. Adv Drug Deliv Rev 107:17–46. https://doi.org/10.1016/j.addr.2016.04.003 CrossRef

Nabi H, Rashid I, Ahmad N, Durrani A, Akbar H, Islam S, Bajwa AA, Shehzad W, Ashraf K, Imran N (2017) Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii. Parasitol Res 116(1):359–370. https://doi.org/10.1007/s0043 CrossRef

Oyewumi MO, Kumar A, Cui Z (2010) Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 9(9):1095–1107. https://doi.org/10.1586/erv.10.89 CrossRef

Pagels RF, Prud’homme RK (2015) Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics. J Control Release 219:519–535. https://doi.org/10.1016/j.jconrel.2015.09.001 CrossRef

Pandey SK, Patel DK, Maurya AK, Thakur R, Mishra DP, Vinayak M, Haldar C, Maiti P (2016) Controlled release of drug and better bioavailability using poly (lactic acid-co-glycolic acid) nanoparticles. Int J Biol Macromol 89:99–110. https://doi.org/10.1016/j.ijbiomac.2016.04.065 CrossRef

Panyam J, Labhasetwar V (2003) Dynamics of endocytosis and exocytosis of poly (D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20(2):212–220. https://doi.org/10.1023/A:1022219003551 CrossRef

Panyam J, Zhou W-Z, Prabha S, Sahoo SK, Labhasetwar V (2002) Rapid endo-lysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16(10):1217–1226. https://doi.org/10.1096/fj.02-0088com CrossRef

Parumasivam T, Leung SSY, Quan DH, Triccas JA, Britton WJ, Chan H-K (2016) Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: preparation and in vitro aerosol characterization. Eur J Pharm Sci 88(Supplement C):1–11. https://doi.org/10.1016/j.ejps.2016.03.024 CrossRef

Pei Y, Mohamed MF, Seleem MN, Yeo Y (2017) Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages. J Control Release 267:133. https://doi.org/10.1016/j.jconrel.2017.08.007 CrossRef

Peres C, Matos AI, Conniot J, Sainz V, Zupančič E, Silva JM, Graça L, Gaspar RS, Préat V, Florindo HF (2017) Poly (lactic acid)-based particulate systems are promising tools for immune modulation. Acta Biomater 48:41–57. https://doi.org/10.1016/j.actbio.2016.11.012 CrossRef

Peyre M, Audran R, Estevez F, Corradin G, Gander B, Sesardic D, Johansen P (2004) Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions. J Control Release 99(3):345–355. https://doi.org/10.1016/j.jconrel.2004.07.014 CrossRef

Qu S, Zhao L, Zhu J, Wang C, Dai C, Guo H, Hao Z (2017) Preparation and testing of cefquinome-loaded poly lactic-co-glycolic acid microspheres for lung targeting. Drug Deliv 24(1):745–751. https://doi.org/10.1080/10717544.2017.1321058 CrossRef

Raudszus B, Mulac D, Langer K (2018) A new preparation strategy for surface modified PLA nanoparticles to enhance uptake by endothelial cells. Int J Pharm 536(1):211–221. https://doi.org/10.1016/j.ijpharm.2017.11.047 CrossRef

Roointan A, Kianpour S, Memari F, Gandomani M, Gheibi Hayat SM, Mohammadi-Samani S (2018) Poly (lactic-co-glycolic acid): the most ardent and flexible candidate in biomedicine! Int J Polym Mater Polym Biomater 67:1–22. https://doi.org/10.1080/00914037.2017.1405350 CrossRef

Roopngam P, Liu K, Mei L, Zheng Y, Zhu X, Tsai H-I, Huang L (2016) Hepatitis C virus E2 protein encapsulation into poly d, l-lactic-co-glycolide microspheres could induce mice cytotoxic T-cell response. Int J Nanomedicine 11:5361. https://doi.org/10.2147/IJN.S109081 CrossRef

Ruge CA, Hillaireau H, Grabowski N, Beck-Broichsitter M, Cañadas O, Tsapis N, Casals C, Nicolas J, Fattal E (2016) Pulmonary surfactant protein A-mediated enrichment of surface-decorated polymeric nanoparticles in alveolar macrophages. Mol Pharm 13(12):4168–4178. https://doi.org/10.1021/acs.molpharmaceut.6b00773 CrossRef

Sabaeifard P, Abdi-Ali A, Gamazo C, Irache JM, Soudi MR (2017) Improved effect of amikacin-loaded poly (D, L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa. J Med Microbiol 66(2):137–148. https://doi.org/10.1099/jmm.0.000430 CrossRef

Saffer EM, Tew GN, Bhatia SR (2011) Poly (lactic acid)-poly (ethylene oxide) block copolymers: new directions in self-assembly and biomedical applications. Curr Med Chem 18(36):5676–5686. https://doi.org/10.2174/092986711798347324 CrossRef

Sahin A, Esendagli G, Yerlikaya F, Caban-Toktas S, Yoyen-Ermis D, Horzum U, Aktas Y, Khan M, Couvreur P, Capan Y (2017) A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of intracellular delivery. Artif Cells Nanomed Biotechnol 45:1–11. https://doi.org/10.1080/21691401.2016.1276924 CrossRef

Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L (2016) Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases. J Control Release 235:34–47. https://doi.org/10.1016/j.jconrel.2016.05.044 CrossRef

Seok H, Noh JY, Lee DY, Kim SJ, Song CS, Kim YC (2017) Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles. J Control Release 265:66. https://doi.org/10.1016/j.jconrel.2017.04.027 CrossRef

Shah RR, O’Hagan DT, Amiji MM, Brito LA (2014) The impact of size on particulate vaccine adjuvants. Nanomedicine 9(17):2671–2681. https://doi.org/10.2217/nnm.14.193 CrossRef

Silva A, Soema P, Slütter B, Ossendorp F, Jiskoot W (2016) PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity. Hum Vaccin Immunother 12(4):1056–1069. https://doi.org/10.1080/21645515.2015.1117714 CrossRef

Song C, Noh Y-W, Lim YT (2016) Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response. Int J Nanomedicine 11:3753. https://doi.org/10.2147/IJN.S110796 CrossRef

Steinbach JM, Seo Y-E, Saltzman WM (2016) Cell penetrating peptide-modified poly (lactic-co-glycolic acid) nanoparticles with enhanced cell internalization. Acta Biomater 30:49–61. https://doi.org/10.1016/j.actbio.2015.11.029 CrossRef

Suk JS, Xu Q, Kim N, Hanes J, Ensign LM (2016) PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99:28–51. https://doi.org/10.1016/j.addr.2015.09.012 CrossRef

Sun Z, Yan X, Liu Y, Huang L, Kong C, Qu X, Wang M, Gao R, Qin H (2017) Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin. Oncotarget 8(35):58823. https://doi.org/10.18632/oncotarget.19221 CrossRef

Tan Z, Liu W, Liu H, Li C, Zhang Y, Meng X, Tang T, Xi T, Xing Y (2017) Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection. Eur J Pharm Biopharm 111:33–43. https://doi.org/10.1016/j.ejpb.2016.11.007 CrossRef

Thomas N, Thorn C, Richter K, Thierry B, Prestidge C (2016) Efficacy of poly-lactic-co-glycolic acid micro-and nanoparticles of ciprofloxacin against bacterial biofilms. J Pharm Sci 105(10):3115–3122. https://doi.org/10.1016/j.xphs.2016.06.022 CrossRef

Tran TH, Tran TTP, Nguyen HT, Dai Phung C, Jeong J-H, Stenzel MH, Jin SG, Yong CS, Truong DH, Kim JO (2018) Nanoparticles for dendritic cell-based immunotherapy. Int J Pharm 542:253. https://doi.org/10.1016/j.ijpharm.2018.03.029 CrossRef

Türeli NG, Torge A, Juntke J, Schwarz BC, Schneider-Daum N, Türeli AE, Lehr C-M, Schneider M (2017) Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections. Eur J Pharm Biopharm 117:363–371. https://doi.org/10.1016/j.ejpb.2017.04.032 CrossRef

Tzeng SY, Guarecuco R, McHugh KJ, Rose S, Rosenberg EM, Zeng Y, Langer R, Jaklenec A (2016) Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release. J Control Release 233:101–113. https://doi.org/10.1016/j.jconrel.2016.05.012 CrossRef

Vasir JK, Labhasetwar V (2007) Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 59(8):718–728. https://doi.org/10.1016/j.addr.2007.06.003 CrossRef

Wan F, Yang M (2016) Design of PLGA-based depot delivery systems for biopharmaceuticals prepared by spray drying. Int J Pharm 498(1):82–95. https://doi.org/10.1016/j.ijpharm.2015.12.025 CrossRef

Wang Q, Barry MA, Seid CA, Hudspeth EM, McAtee CP, Heffernan MJ (2017) 3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine. J Biomed Mater Res B Appl Biomater 106:1587. https://doi.org/10.1002/jbm.b.33965 CrossRef

Watkins HC, Pagan CL, Childs HR, Posada S, Chau A, Rios J, Guarino C, DeLisa MP, Whittaker GR, Putnam D (2017) A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles. Vaccine 35:5373. https://doi.org/10.1016/j.vaccine.2017.08.013 CrossRef

Yang HW, Ye L, Guo XD, Yang C, Compans RW, Prausnitz MR (2017) Ebola vaccination using a DNA vaccine coated on PLGA-PLL/γPGA nanoparticles administered using a microneedle patch. Adv Healthc Mater 6(1). https://doi.org/10.1002/adhm.201600750 CrossRef

Zhang N-Z, Xu Y, Wang M, Chen J, Huang S-Y, Gao Q, Zhu X-Q (2016) Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly (lactide-co-glycolide) microspheres induces long-term protective immunity in mice. BMC Infect Dis 16(1):168. https://doi.org/10.1186/s12879-016-1496-0 CrossRef

Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y (2011) Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 7(10):1322–1337. https://doi.org/10.1002/smll.201100001 CrossRef

Title: Poly-lactide/Poly-lactide-co-glycolide-Based Delivery System for Bioactive Compounds Against Microbes
Authors: Robin Kumar
Divya Jha
Amulya K. Panda
Publisher: Springer International Publishing
Book: Pharmaceuticals from Microbes
Print ISBN: 978-3-030-01880-1

Electronic ISBN: 978-3-030-01881-8

Copyright Year: 2019
DOI: https://doi.org/10.1007/978-3-030-01881-8_3